BriaCell Therapeutics (TSE:BCT) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
BriaCell Therapeutics has announced its plans to sell common shares and warrants in an underwritten public offering. The company aims to use the proceeds for working capital, corporate purposes, and advancing its business goals. The offering’s completion depends on market conditions and there is no guarantee it will be finalized.
For further insights into TSE:BCT stock, check out TipRanks’ Stock Analysis page.
